Company intelligence / Profile preview

DeepSeek

Hangzhou, Zhejiang, Chinadeepseek.com ↗

Ownership: Private
Development stage: Other

Overview

DeepSeek’s AI models have demonstrated pharma-grade accuracy in predicting molecular interactions and identifying promising compounds at a fraction of traditional compute costs. The system was notably leveraged during the COVID-19 pandemic to rapidly analyze millions of molecular combinations, expediting antiviral candidate identification. Its performance rivals leading US-developed models but with dramatically lower training costs ($5.6–$6 million vs $100M+), making it highly disruptive in both tech and biotech sectors.

Modalities: Small molecule discoveryProtein interaction prediction
Industry: Drug Discovery Services

Partnerships

Fosun PharmaWuXi AppTec

Beyond the preview

Go deeper on DeepSeek.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DeepSeek.

Explore the full profile